Biodesix advances blood-based cancer monitoring programs
Biodesix (NASDAQ:BDSX) announced progress on two molecular residual disease (MRD) testing programs designed to detect circulating tumor DNA (ctDNA) in blood samples following cancer treatment.
Todas as matérias desta seção, das mais recentes às mais antigas — página 47 de 371.
Biodesix (NASDAQ:BDSX) announced progress on two molecular residual disease (MRD) testing programs designed to detect circulating tumor DNA (ctDNA) in blood samples following cancer treatment.
Vertiv (NYSE:VRT) agreed on September 24, 2026, to acquire King Environmental Services (KES), a Europe-based provider of fluid-management services for data centers and critical infrastructure applications.
Fervo Energy (NYSE:FRVO) announced that its Cape Station geothermal project in Utah achieved First Power on September 24, 2026, marking the start of electricity exports from the facility.
Sequans Communications (NYSE:SQNS) completed the sale of its remaining 314 Bitcoin holdings, ending its Bitcoin treasury strategy and refocusing on its semiconductor business.
MediciNova (NASDAQ:MNOV) announced the completion of the last patient’s final visit in the double-blind portion of its Phase 2b/3 COMBAT-ALS trial evaluating MN-166 (ibudilast) for amyotrophic lateral sclerosis (ALS).
aTyr Pharma (NASDAQ:ATYR) announced FDA alignment on the planned Phase 3 study protocol for efzofitimod in patients with pulmonary sarcoidosis on September 24, 2026.
Kyverna Therapeutics (NASDAQ:KYTX) reported updated clinical data for its investigational CAR-T therapy miv-cel (mivocabtagene autoleucel) in stiff person syndrome (SPS) and generalized myasthenia gravis (gMG).
RTX (NYSE:RTX) and United Airlines marked the delivery of the first Airbus A321XLR aircraft powered by Pratt & Whitney’s GTF Advantage engine on September 24, 2026.
MGM Resorts International (NYSE:MGM) shares fell 8.38% to $34.68 in premarket trading after People withdrew its proposal to acquire the remaining public shares of the casino operator.
Oil prices rose more than 2% on Thursday as uncertainty over US-Iran negotiations and possible diesel export restrictions supported crude prices.
Uxin (NASDAQ:UXIN) reported revenue of RMB1,151.2 million for the quarter ended June 30, 2026, an increase of 74.9% from the same period last year.
Four Corners Property Trust (NYSE:FCPT) acquired an automotive service property leased to a national operator for $3.5 million through a sale-leaseback transaction.
HUTCHMED (NASDAQ:HCM) will present results from two Phase III studies evaluating savolitinib combined with osimertinib in lung cancer patients at ESMO Congress 2026.
Clorox (NYSE:CLX) declared a quarterly dividend of $1.25 per common share on September 23, 2026, with payment scheduled for November 13, 2026.
Better Home & Finance (NASDAQ:BETR) opened an investigation into allegations that director and former CEO Vishal Garg sought to exchange company interests and property for shareholder consents supporting his proposal to replace the board.
Afya (NASDAQ:AFYA) entered a binding merger agreement with Yduqs Participações S.A. to combine the two Brazilian higher education companies.
AtlasClear Holdings (NYSE:ATCH) reported fiscal 2026 revenue of $20.1 million for the year ended June 30, 2026, representing an 85% increase from the prior year.
Greenland Mines (NASDAQ:GRML) announced more than $42 million in equity financing on September 24, 2026, through a registered direct offering and warrant exercises.
RTX (NYSE:RTX) subsidiary Pratt & Whitney Canada signed a four-year maintenance agreement with AirBorneo Airways covering PW127M engines used on its ATR 72-500 turboprop aircraft.
Jacobs (NYSE:J) will continue supporting thyssenkrupp Steel’s hydrogen-capable direct reduction plant in Duisburg, Germany, through an extended project management and construction services contract.
Novartis (NYSE:NVS) won a lawsuit in Manhattan federal court after a judge dismissed claims that the company improperly used an Entresto patent listing to delay generic competition.
Devon Energy (NYSE:DVN) received a letter from Toms Capital Management urging the company to explore strategic alternatives, including a potential sale of the entire company.
Bio-Techne (NASDAQ:TECH) shareholders approved the proposed acquisition by Merck KGaA, Darmstadt, Germany, at a special meeting held on September 23, 2026.
Tem um segundo para um cookie? 🍪Os cookies essenciais mantêm a Grafa funcionando bem. Alguns opcionais nos ajudam a ver o que está funcionando para melhorarmos. Você tem o controle — pode mudar de ideia quando quiser. Política de cookies · Política de privacidade